Uniavisen
Københavns Universitet
Uafhængig af ledelsen

Foredrag

Copenhagen Bioscience Lecture August 31, 2017 - "The future of diabetes research"

Foredrag — The Copenhagen Bioscience Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. The lecture on 31 August 2017 features Philippe Halban, former president of the European Association for the Study of Diabetes (EASD) and its research Foundation (EFSD) of which he is currently Honorary Chairman, and Allan Flyvbjerg, CEO of Steno Diabetes Center Copenhagen. They will give their insights for opportunities and challenges in diabetes research, from a scientific, clinical and health political view.

Info

Date & Time:

Place:
Novo Nordisk Fonden
Tuborg Havnevej 19
2900 Hellerup

Hosted by:
Copenhagen Bioscience Cluster

Cost:
Free

signup

CONCEPT

The Copenhagen Bioscience Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. Every 4 weeks, on a Thursday evening, you are invited for lectures on themes with a general interest for the Novo Nordisk Foundation Research Centers and bioscience researchers in general. Often there will be a cross-disciplinary focus.

The lecture on 31 August 2017 features Philippe Halban, former president of the European Association for the Study of Diabetes (EASD) and its research Foundation (EFSD) of which he is currently Honorary Chairman, and Allan Flyvbjerg, CEO of Steno Diabetes Center Copenhagen. They will give their insights for opportunities and challenges in diabetes research, from a scientific, clinical and health political view.

PROGRAMME

15:45 Welcome and registration (coffee/tea, water available)

16:00 Start of the lecture

 

17:30  Networking with a drink and a snack

 

18:30 Thank you for a splendid end of day!

 

 

REGISTRATION

Registration is completely free of charge, but mandatory. Online registration at: https://www.eventbrite.com/e/copenhagen-bioscience-lectures-august-31-2017-the-future-of-diabetes-research-tickets-35782831412

 

 

BIOs

Emeritus Professor Philippe Halban

Philippe Halban received a PhD from the University of Oxford. After postdoctoral training in diabetes research in Geneva, Dr. Halban was Senior Investigator at the Joslin Diabetes Center, Boston, USA, before returning to the University of Geneva as Professor of Genetic Medicine and Development, where he is now Emeritus Professor. Dr. Halban’s research has been devoted to the study of beta cells. He has received several major international scientific awards including the EASD Minkowski Prize and the IDF Basic Research Prize. He is also former president of the European Association for the Study of Diabetes (EASD) and its research Foundation (EFSD) of which he is currently Honorary Chairman.

At the lecture on August 31,his talk will focus on the future of  diabetes research from a science policy and funding perspective, with an additional emphasis on the need for a concerted approach involving academia and industry.

 

 

Professor Allan Flyvbjerg

Allan Flyvbjerg graduated from Aarhus University, Denmark in 1986. He defended his thesis (DMSc) in 1993, became specialist in Internal Medicine and Endocrinology in 1999, Chief Physician in 2001, Professor in Experimental Medical Research in 2005 and Professor in Endocrinology (Chair) in 2009 at the Department of Endocrinology/Internal Medicine at Aarhus University Hospital and the Medical Research Laboratories, Department of Clinical Medicine, Aarhus University, Aarhus C., Denmark. From 2010-2016 he was Dean at the Faculty of Health at Aarhus University, Denmark. Since October 2016 he has been CEO of Steno Diabetes Center Copenhagen (SDCC) at the Capital Region of Denmark, Copenhagen, Denmark and since November 2016 Clinical Professor at the University of Copenhagen.

Allan Flyvbjerg and his research team perform preclinical and clinical research focused on the pathogenesis leading to diabetic micro- and macroangiopathy. The aim of the research is to combat the increased incidence and prevalence of cardiovascular disease, blindness and end-stage renal failure in patients with diabetes.

 

 

FAQs

I would like to know about upcoming Copenhagen Bioscience Lectures – where can I find information?

You are very welcome to join the ‘Novo Nordisk Foundation Research Centers’ Linkedin group. There you will find information about upcoming lectures, and much more. Also, you may want to sign up for the weekly announcement with events and deadlines, sent out by the group manager.

 

 

What are my transport/parking options getting to the event?

We can reimburse a taxi from and to Panum or DTU building 220, if you are at least 3 people in a taxi. This is how it works: you arrange yourself for a taxi from Blegdamsvej or from Kemitorvet, find at least 2 other people to share and take the taxi with, at arrival at Tuborg Havnevej 19 you ask Sophie or Gitte to come and pay for the taxi (they’ll check departure address and number of persons in the taxi), as well as to order your taxi back.

You can park for free in front or at the side of Tuborg Havnevej 19. If that is full, there is 3 hours free parking in the parking to the Waterfront shopping mall at the end of the road.

Public transport by train to Hellerup station, and/or bus (1A, 21, 166), nearest by bus stop is Tuborg Boulevard.

 

Where can I contact the organizer with any questions?

Contact Sophie Labrosse at sfeb@novo.dk

 

How do I cancel my participation?

Please help us respecting our speakers, as well keeping track of the numbers and optimize lecture and catering to the audience by cancelling as soon as you know that you exceptionally will not be able to make it. You can either cancel through Eventbrite or send an email to Sophie Labrosse (sfeb@novo.dk).

 

 

Can I update my registration information?

Yes, just log in to Eventbrite. Please use this option also in the unlikely event that you need to cancel your registration.

 

Do I have to bring my printed ticket to the event?

No, you do not have to bring your ticket, but registration is mandatory for participation.

Upcoming